Archive - May 2018
EMA s Demands for Plain-Language Summaries for Clinical Trial Results that can be Understood by Anyone Could Create new Challenges for Sponsors
New Weapons and new Warnings Over Health Research
FDA clears Dova drug for liver-related low blood platelets
Daily Brief: UK must follow through on Life Sciences Strategy, haemophilia gene therapy latest and more
EMA retracts license from Taiwanese sterile drugmaker over serious non-compliance
More encouraging data for Spark and Pfizer’s potential haemophilia B cure
Positive mid-stage trial gives Allergy’s investors some welcome relief
US clears paediatric use of GSK’s Arnuity Ellipta